Skip to search formSkip to main contentSkip to account menu

Gestrinone

Known as: 13-Ethyl-17-Hydroxy-18,19-Dinor-17Alpha-Pregna-4,9,11-Trien-20-Yn-3-One, Pregna-4,9,11-Trien-20-Yn-3-One, 13-Ethyl-17-Hydroxy-18,19-Dinor-, (17Alpha)-, 18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)- 
A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
OBJECTIVE To investigate the incidence, influencing factors and intervention of gestrinone-related abnormal uterine bleeding at… 
2015
2015
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of… 
2014
2014
Cyclic sciatica due to endometriosis involving the sciatic nerve is a rare clinical and pathological entity1,2. Since the first… 
2010
2010
Nine patients with pelvic endometriosis were treated with gestrinone in a dose of 2.5 mg twice weekl- for 6 to 7 months. All… 
2010
2010
OBJECTIVE:To compare efficacy and adverse drug reaction of goserelin and gestrinone after laparoscopic surgery of ovarian… 
2007
2007
Objective:To evaluate the efficiency and treatment time of mifepristone and gestrinone after in treatment of endometriosis… 
1991
1991
Since the 1970s the main thrust of drug research and development in endometriosis has been with danazol and latterly the LHRH… 
1990
1990
In order to adequately assess the effectiveness of danazol, gestrinone, buserelin-nasal spray (IN) and buserelin-implant (SC), a… 
1975
1975
2 tablets of the drug (25 mg each ethylnorgestrienone) were administered weekly to a group of 50 men who had received…